Skip to main content
Log in

Impact of prophylactic intracameral moxifloxacin on post-cataract surgery endophthalmitis: data from a tertiary eye care facility in rural India

  • Original Paper
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

To study the impact of prophylactic intracameral (IC) moxifloxacin on the incidence, clinical profile and outcomes in eyes developing post-cataract surgery endophthalmitis (PCE).

Methods

This was a single-centre, retrospective, comparative, observational study in which all eyes with PCE between June 2013 and May 2014 without IC moxifloxacin prophylaxis (group A) and June 2015–May 2016 with IC moxifloxacin prophylaxis (group B) were analysed.

Results

A total of 101,815 cataract surgeries were performed in group A and 112,967 in group B. PCE was diagnosed in 179 eyes (0.18%) in group A and 92 eyes (0.08%) in group B (p < 0.001). Greater reduction in risk of PCE was seen in subsidised patients compared to private. The presenting and final visual acuity was significantly better in group B (p < 0.05).

Conclusions

Prophylactic IC moxifloxacin reduced the incidence of PCE with maximum benefit being observed for the subsidised patients and also helped achieve a significantly better visual acuity following the resolution of endophthalmitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Data availability

Data are available upon request.

References

  1. Endophthalmitis Study Group, European Society of Cataract & Refractive Surgeons. Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg 2007;33:978‐988

  2. Speaker MG, Milch FA, Shah MK et al (1991) Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis. Ophthalmology 98:639–650

    Article  CAS  Google Scholar 

  3. Haripriya A, Chang DF, Namburar S et al (2016) Efficacy of intracameral moxifloxacin endophthalmitis prophylaxis at Aravind Eye Hospital. Ophthalmology 123:302–308

    Article  Google Scholar 

  4. Haripriya A, Chang DF, Ravindran RD (2017) Endophthalmitis reduction with intracameral moxifloxacin prophylaxis: analysis of 600 000 surgeries. Ophthalmology 124:768–775

    Article  Google Scholar 

  5. Results of the Endophthalmitis Vitrectomy Study (1995) A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Endophthalmitis Vitrectomy Study Group Arch Ophthalmol 113:1479–1496

    Google Scholar 

  6. Jambulingam M, Parameswaran SK, Lysa S et al (2010) A study on the incidence, microbiological analysis and investigations on the source of infection of postoperative infectious endophthalmitis in a tertiary care ophthalmic hospital: an 8-year study. Indian J Ophthalmol 58:297–302

    Article  Google Scholar 

  7. Ravindran RD, Venkatesh R, Chang DF et al (2009) Incidence of post-cataract endophthalmitis at Aravind Eye Hospital: outcomes of more than 42,000 consecutive cases using standardized sterilization and prophylaxis protocols. J Cataract Refract Surg 35:629–636

    Article  Google Scholar 

  8. Npcbvi.gov.in. 2020. NPCBVI. [online] Available at: <https://npcbvi.gov.in/> [Accessed 8 August 2020]

  9. Chang DF, Braga-Mele R, Mamalis N et al (2007) Prophylaxis of postoperative endophthalmitis after cataract surgery: results of the 2007 ASCRS member survey. J Cataract Refract Surg 33:1801–1805

    Article  Google Scholar 

  10. Arbisser LB (2008) Safety of intracameral moxifloxacin for prophylaxis of endophthalmitis after cataract surgery. J Cataract Refract Surg 34:1114–1120

    Article  Google Scholar 

  11. Lane SS, Osher RH, Masket S et al (2008) Evaluation of the safety of prophylactic intracameral moxifloxacin in cataract surgery. J Cataract Refract Surg 34:1451–1459

    Article  Google Scholar 

  12. Matsuura K, Miyoshi T, Suto C et al (2013) Efficacy and safety of prophylactic intracameral moxifloxacin injection in Japan. J Cataract Refract Surg 39:1702–1706

    Article  Google Scholar 

  13. Rathi VM, Sharma S, Das T et al (2020) Endophthalmitis prophylaxis study. Report 1: intracameral cefuroxime and moxifloxacin prophylaxis for the prevention of postcataract endophthalmitis in rural India. Indian J Ophthalmol 68:819–824

    Article  Google Scholar 

  14. Celebi S, Ay S, Aykan U, Bulut V, Alagöz G, Celiker UO (1998) Penetration of oral and topical ciprofloxacin into human aqueous humor. Acta Ophthalmol Scand 76(6):683–685

    Article  CAS  Google Scholar 

  15. Venkatesh R, Muralikrishnan R, Balent LC et al (2005) Outcomes of high volume cataract surgeries in a developing country. Br J Ophthalmol 89:1079–1083

    Article  CAS  Google Scholar 

  16. Ruit S, Tabin G, Chang D et al (2007) A prospective randomized clinical trial of phacoemulsification vs manual sutureless small-incision extracapsular cataract surgery in Nepal. Am J Ophthalmol 143:32–38

    Article  Google Scholar 

  17. Haripriya A, Chang DF, Reena M et al (2012) Complication rates of phacoemulsification and manual small-incision cataract surgery at Aravind Eye Hospital. J Cataract Refract Surg 38:1360–1369

    Article  Google Scholar 

  18. Cao H, Zhang L, Li L et al (2013) Risk factors for acute endophthalmitis following cataract surgery: a systematic review and meta-analysis. PLoS ONE 8:e71731

    Article  CAS  Google Scholar 

  19. Haripriya A, Chang DF, Ravindran RD (2019) Endophthalmitis reduction with intracameral moxifloxacin in eyes with and without surgical complications: results from 2 million consecutive cataract surgeries. J Cataract Refract Surg 45:1226–1233

    Article  Google Scholar 

  20. Arshinoff SA, Felfeli T, Modabber M (2019) Aqueous level abatement profiles of intracameral antibiotics: a comparative mathematical model of moxifloxacin, cefuroxime, and vancomycin with determination of relative efficacies. J Cataract Refract Surg 45:1568–1574

    Article  Google Scholar 

  21. Peñaranda-Henao MMD, Reyes-Guanes JMS, Muñoz-Ortiz JMD, Gutiérrez ÁMMD, PhD D-L-T (2020) Anterior uveitis due to intracameral moxifloxacin: a case report. Ocul Immunol Inflamm 29:1–4

    Article  Google Scholar 

Download references

Funding

No funding was received for conducting this study.

Author information

Authors and Affiliations

Authors

Contributions

AS, PS, RK, DS and PS designed and conducted the study; RK, MS, VN and PB collected and analysed the data; PS, AS, RA, EG and GMK prepared, reviewed and approved the manuscript.

Corresponding author

Correspondence to Alok Sen.

Ethics declarations

Conflict of interest

The authors report no conflicts of interest.

Ethical approval

The study was performed according to the Declaration of Helsinki and was approved by the institutional review board of the institute.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shenoy, P., Goh, E.J.H., Kashikar, R. et al. Impact of prophylactic intracameral moxifloxacin on post-cataract surgery endophthalmitis: data from a tertiary eye care facility in rural India. Int Ophthalmol 41, 2729–2736 (2021). https://doi.org/10.1007/s10792-021-01830-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-021-01830-0

Keywords

Navigation